Poly Medicure
Ticker > Company >

Poly Medicure share price

Poly Medicure Ltd.

NSE: POLYMED BSE: 531768 SECTOR: Medical Equipment/Supplies/Accessories  1.33 L   577   79

1989.40
+5.80 (0.29%)
NSE: Today, 04:07 PM

Price Summary

Today's High

₹ 2005

Today's Low

₹ 1982

52 Week High

₹ 3357.8

52 Week Low

₹ 1821.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 20157.74 Cr.

Enterprise Value

₹ 20184.4 Cr.

No. of Shares

10.13 Cr.

P/E

58.1

P/B

7.12

Face Value

₹ 5

Div. Yield

0.18 %

Book Value (TTM)

₹  279.28

CASH

₹ 143.19 Cr.

DEBT

₹ 169.86 Cr.

Promoter Holding

62.44 %

EPS (TTM)

₹  34.24

Sales Growth

22.53%

ROE

15.79 %

ROCE

20.14%

Profit Growth

31.63 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 21Indices.

NYMIDSML400MQ100

Nifty MidSmallcap400 Momentum Quality 100 Index
49352.45
  395.699999999997 (0.808264437488182%)

NFTSML250MOMQ100

Nifty Smallcap250 Momentum Quality 100 index
46613
  488.599999999999 (1.05930917258543%)

NFTMIDSMLHEALTH

Nifty MidSmall Healthcare
44945.85
  -102.200000000004 (-0.226868865577989%)

NFTSMLCAP250Q50

Nifty Smallcap250 Quality 50
27216.25
  131.599999999999 (0.485884070866693%)

NIFTY500

Nifty 500
23369.3
  153.450000000001 (0.660970845349196%)

NIFTYMIDSMALL400

Nifty MidSmallcap 400
20216.8
  132.849999999999 (0.661473465130102%)

NIF500LGMIDSML

Nifty500 LargeMidSmall Equal-Cap Weighted Index
18012.65
  120.450000000001 (0.673198376946393%)

NIFTYSMALLCAP250

Nifty Smallcap 250
17382.2
  127.950000000001 (0.741556428126411%)

NY500MUL50:25:25

Nifty500 Multicap 50:25:25
16311.1
  108.550000000001 (0.669956272315164%)

NFT500EQUAL

Nifty 500 Equal Weight
14585.75
  90.0499999999993 (0.621218706237014%)

NIFTYTOTALMCAP

Nifty Total Market index
13154.7
  85.8000000000011 (0.656520441659225%)

SHARIAH500

Nifty500 Shariah
7229.4
  39.5999999999995 (0.550780272052065%)

SMLCAP

S&P Bse Small Cap
54260.04
  356.849999999999 (0.662020188415569%)

BSE HC

S&P Bse Healthcare
44776.17
  57.6899999999951 (0.129007068218767%)

BSE500

S&P Bse 500
36697.39
  244.409999999996 (0.670480163761633%)

S&P MIDSMLCAP

S&P Bse MidSmallCap
12414.1
  73.2299999999996 (0.593394144821224%)

MSL400

S&P Bse 400 MidSmallCap
12255.8
  84.619999999999 (0.695248940529991%)

BSE1000

Bse 1000
10936.05
  71.8499999999985 (0.661346440603072%)

ALLCAP

S&P Bse Allcap
10130.99
  38.3799999999992 (0.380278243189802%)

SHA500

S&P Bse 500 Shariah
9113.66
  125.5 (1.39628133010539%)

SML250

S&P Bse 250 SmallCap
6956.27
  51.5800000000008 (0.7470284690551%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.53%
3 Year22.13%
5 Year19.91%

Profit Growth

1 Year31.63%
3 Year31.41%
5 Year29.1%

ROE%

1 Year15.79%
3 Year16.68%
5 Year16.64%

ROCE %

1 Year20.14%
3 Year20.92%
5 Year20.41%

Debt/Equity

0.0619

Price to Cash Flow

85.18

Interest Cover Ratio

33.7968

CFO/PAT (5 Yr. Avg.)

0.898424835943701

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 62.44 0.00
Mar 2025 62.44 0.00
Dec 2024 62.44 0.00
Sep 2024 62.56 0.00
Jun 2024 66.03 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 31.4077766749921% for the Past 3 years.
  • The company has shown a good revenue growth of 22.127472653182% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 20.9189666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 33.7968.
  • The Company has been maintaining an effective average operating margins of 26.3204055130091% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 46.8866 days.
  • Company has a healthy liquidity position with current ratio of 4.5361.
  • The company has a high promoter holding of 62.44%.

 Limitations

  • The company is trading at a high PE of 58.1.
  • The company is trading at a high EV/EBITDA of 35.8587.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 367.43 402.47 410.94 420.97 384.05
Total Expenditure 266.35 289.54 295.34 304.93 282.42
Operating Profit 101.08 112.93 115.6 116.04 101.63
Other Income 16.83 27.24 21.75 23.95 41.1
Interest 2.98 3.13 3.13 2.17 2.81
Depreciation 18.85 20.11 20.83 21.33 22.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 96.08 116.93 113.39 116.5 117.06
Tax 23.77 29.71 28.24 29.84 29.14
Profit After Tax 72.3 87.22 85.15 86.66 87.93
Adjusted EPS (Rs) 7.53 8.61 8.4 8.55 8.68

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 747.38 879.36 1068.05 1307.25 1601.8
Total Expenditure 537.03 665.47 801.67 956.11 1154.34
Operating Profit 210.36 213.89 266.37 351.14 447.46
Other Income 19.29 38.73 36.29 58.18 89.77
Interest 9.95 5.36 10.19 12.85 13.5
Depreciation 46.31 52.54 55.64 61.57 80.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 173.38 194.72 236.83 334.89 442.89
Tax 43.87 48.7 57.78 83.17 111.56
Net Profit 129.51 146.02 179.04 251.72 331.33
Adjusted EPS (Rs.) 13.51 15.23 18.66 26.23 32.7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 47.94 47.95 47.97 47.99 50.66
Total Reserves 906.07 1029.02 1186.15 1410.26 2693.56
Borrowings 59.74 30.56 11.56 0.84 0
Other N/C liabilities 21.67 23.15 23.13 34.75 54.34
Current liabilities 195.54 203.27 326.81 400.32 429.44
Total Liabilities 1230.96 1333.96 1595.63 1894.16 3228
Assets
Net Block 384.97 447.46 597.43 830.82 1047.35
Capital WIP 14.74 37.11 72.53 66.67 89.47
Intangible WIP 6.43 5.86 5.21 4.04 3.32
Investments 39.8 46.94 56.96 81.07 70.66
Loans & Advances 12.73 31.85 41.89 38.63 55.5
Other N/C Assets 55.06 23.75 8.49 8.33 13.73
Current Assets 717.23 740.99 813.13 864.59 1947.98
Total Assets 1230.96 1333.96 1595.63 1894.16 3228
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 173.38 194.72 236.83 334.89 442.89
Adjustment 44.94 38.6 60.17 35.82 36.36
Changes in Assets & Liabilities -57.79 -60.19 -42.33 -40.87 -153.59
Tax Paid -44.14 -46.86 -57.84 -73.74 -89.01
Operating Cash Flow 116.4 126.26 196.83 256.1 236.65
Investing Cash Flow -434.41 -88.71 -189.18 -237.02 -1191.17
Financing Cash Flow 318.92 -39.71 -7.89 -17.32 952.93
Net Cash Flow 0.9 -2.16 -0.25 1.76 -1.59

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 66.03 62.56 62.44 62.44 62.44
aaryaman baid 0.29 0.28 0.28 0.28 0.28
arham baid 0.29 0.28 0.28 0.28 0.28
dhruv baid 0.38 0.36 0.36 0.36 0.36
ezekiel global business s... 12.88 12.20 12.20 12.20 12.20
himanshu baid 8.24 7.81 7.80 7.80 7.80
himanshu baid (huf) - 3.79 3.79 3.79 3.79
jai polypan private limit... - - - - 3.26
jugal kishore baid 2.38 2.25 2.25 2.25 2.25
madhu kothari 0.16 0.15 0.15 0.15 0.15
neha baid 1.07 1.01 1.01 - 1.01
polycure martech limited 0.01 0.01 0.01 0.01 0.01
rishi baid 10.18 9.64 9.59 9.59 9.59
rishi baid (huf) - 2.74 2.74 2.74 2.74
shaily baid 1.24 1.17 1.17 1.17 1.17
shireen baid - - - 1.11 1.11
smt. mukulika baid - 3.02 3.02 3.02 3.02
vcb trading llp 3.69 3.50 3.49 3.49 3.49
vinay kothari 0.06 0.06 0.06 0.06 0.06
vishal baid 1.75 1.66 1.66 1.66 1.66
zetta matrix consulting l... 8.67 8.22 8.21 8.21 8.21
jai polypan pvt. ltd. - 3.31 3.26 3.26 -
neha baid - - - 1.01 -
shireen baid 1.17 1.11 1.11 - -
himanshu baid (huf) 4.00 - - - -
jai polypan pvt. ltd 3.49 - - - -
rishi baid(huf) 2.90 - - - -
smt.mukulika baid 3.19 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 33.97 37.44 37.56 37.56 37.56
axis max life insurance l... - - - 1.94 2.03
lighthouse india fund iv ... - 1.16 1.37 1.37 1.37
nirmala vinodkumar daga 2.12 1.84 1.80 1.80 1.79
quant mutual fund - quant... - - - 3.35 3.52
shreans daga 1.53 1.45 1.43 1.43 1.43
smallcap world fund, inc 2.26 1.79 1.66 1.66 2.02
uti nifty midsmallcap 400... - - - - 1.50
varun daga 1.62 1.54 1.54 1.54 1.54
uti nifty midsmallcap 400... - - - 1.62 -
max life insurance co ltd... - - 1.67 - -
quant mutual fund - quant... - 3.51 3.51 - -
uti - healthcare fund 2.02 1.78 1.66 - -
max life insurance compan... - 1.71 - - -
max life insurance compan... 1.54 - - - -
quant mutual fund - quant... 3.43 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q1FY26
Concall Q1FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY21
Presentation Q1FY26
Presentation FY2024

Company News

Poly Medicure informs about conference call 5 Sep, 10:38 AM Poly Medicure gets nod to acquire PendraCare Group 4 Sep, 11:08 AM Poly Medicure informs about analyst meet 28 Aug, 5:30 PM Poly Medicure - Quaterly Results 8 Aug, 2:31 PM Poly Medicure - Quaterly Results 8 Aug, 2:31 PM Poly Medicure - Quaterly Results 8 Aug, 2:31 PM Poly Medicure informs about grant of options 4 Jun, 5:35 PM Poly Medicure reports 34% jump in Q4 consolidated net profit 7 May, 3:22 PM Poly Medicure informs about press release 7 May, 12:15 PM Poly Medicure - Quaterly Results 6 May, 10:28 PM Poly Medicure - Quaterly Results 6 May, 10:28 PM Poly Medicure receives MDR certification for 54 products 11 Mar, 4:41 PM Poly Medicure incorporates wholly owned Step-down subsidiary 6 Feb, 9:14 AM Poly Medicure informs about unaudited financial results 3 Feb, 4:51 PM Poly Medicure - Quaterly Results 3 Feb, 2:30 PM Poly Medicure - Quaterly Results 3 Feb, 2:30 PM Poly Medicure - Quaterly Results 3 Feb, 2:30 PM Poly Medicure enters into JV agreement with AMPIN C&I Power 10 Jan, 6:42 PM Poly Medicure - Quaterly Results 28 Oct, 2:17 PM Poly Medicure - Quaterly Results 28 Oct, 2:17 PM Poly Medicure - Quaterly Results 28 Oct, 2:17 PM Poly Medicure informs about investor presentation 24 Jul, 4:41 PM Poly Medicure - Quaterly Results 22 Jul, 1:19 PM Poly Medicure - Quaterly Results 22 Jul, 1:19 PM Poly Medicure - Quaterly Results 22 Jul, 1:19 PM Poly Medicure - Quaterly Results 17 May, 2:08 PM Poly Medicure - Quaterly Results 17 May, 2:08 PM Poly Medicure - Quaterly Results 17 May, 2:08 PM Poly Medicure - Quaterly Results 31 Jan, 11:59 AM Poly Medicure - Quaterly Results 31 Jan, 11:59 AM Poly Medicure - Quaterly Results 31 Jan, 11:59 AM Poly Medicure - Quaterly Results 4 Nov, 1:47 PM Poly Medicure - Quaterly Results 4 Nov, 1:47 PM Poly Medicure - Quaterly Results 4 Nov, 1:47 PM Poly Medicure - Quaterly Results 7 Aug, 12:10 PM Poly Medicure - Quaterly Results 7 Aug, 12:10 PM Poly Medicure - Quaterly Results 7 Aug, 12:10 PM Poly Medicure - Quaterly Results 9 May, 12:57 PM Poly Medicure - Quaterly Results 9 May, 12:57 PM Poly Medicure - Quaterly Results 9 May, 12:57 PM Poly Medicure - Quaterly Results 28 Jan, 12:39 PM Poly Medicure - Quaterly Results 28 Jan, 12:39 PM Poly Medicure - Quaterly Results 28 Jan, 12:39 PM Poly Medicure informs about board meeting 17 Jan, 12:33 PM Poly Medicure - Quaterly Results 4 Nov, 12:38 PM Poly Medicure - Quaterly Results 4 Nov, 12:38 PM Poly Medicure - Quaterly Results 4 Nov, 12:38 PM Poly Medicure - Quaterly Results 4 Aug, 12:21 PM Poly Medicure - Quaterly Results 4 Aug, 12:21 PM Poly Medicure - Quaterly Results 4 Aug, 12:21 PM

Poly Medicure Stock Price Analysis and Quick Research Report. Is Poly Medicure an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Poly Medicure. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Poly Medicure has a PE ratio of 58.098411595151 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Poly Medicure has ROA of 12.9373% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Poly Medicure has a Current ratio of 4.5361.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Poly Medicure has a ROE of 15.7899%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Poly Medicure has a Debt to Equity ratio of 0.0619 which means that the company has low proportion of debt in its capital.

  • Sales growth: Poly Medicure has reported revenue growth of 22.5321% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Poly Medicure for the current financial year is 27.934939185284%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Poly Medicure is Rs 3.5 and the yield is 0.1768%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Poly Medicure is Rs 34.2419. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Poly Medicure in Ticker for free. Also, one can get the intrinsic value of Poly Medicure by using Valuation Calculators, which are available with a Finology ONE subscription. 

Poly Medicure FAQs

Q1. What is Poly Medicure share price today?
Ans: The current share price of Poly Medicure is Rs 1989.4.

Q2. What is the market capitalisation of Poly Medicure?
Ans: Poly Medicure has a market capitalisation of Rs 20157.7377421 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Poly Medicure?
Ans: The PE ratio of Poly Medicure is 58.098411595151 and the P/B ratio of Poly Medicure is 7.12321507855803, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Poly Medicure share?
Ans: The 52-week high share price of Poly Medicure is Rs 3357.8, and the 52-week low share price of Poly Medicure is Rs 1821.2.

Q5. Does Poly Medicure pay dividends?
Ans: Currently, Poly Medicure pays dividends. Dividend yield of Poly Medicure is around 0.1768%.

Q6. What are the face value and book value of Poly Medicure shares?
Ans: The face value of Poly Medicure shares is Rs 5, while the book value per share of Poly Medicure is around Rs 279.284. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Poly Medicure?
Ans: Poly Medicure has a total debt of Rs 169.8593 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Poly Medicure?
Ans: The ROE of Poly Medicure is 15.7899% and ROCE of Poly Medicure is 20.1381%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Poly Medicure a good buy for the long term?
Ans: The Poly Medicure long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Poly Medicure undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Poly Medicure appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Poly Medicure’s financials?
Ans: You can review Poly Medicure’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Poly Medicure

Poly Medicure Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

Poly Medicure Ltd. is a leading medical device company in India. In this article, we will provide a comprehensive analysis of the company's stock, including its share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall transcripts, investor presentations, promoters, and shareholders. Our website provides pre-built screening tools and premium features such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. Additionally, we provide downloadable annual reports and quarterly results for investors to analyze.

Poly Medicure Ltd. Share Price

The share price of Poly Medicure Ltd. is an important factor to consider before investing. It reflects the market's perception of the company's performance. A stock's share price is determined by a range of factors, such as market sentiment, financial performance, and general economic conditions. Our pre-built screening tools can help investors analyze the stock price and its trend. Investors should analyze the trend of the share price over a period of time to make informed decisions.

Poly Medicure Ltd. Balance Sheet

The balance sheet of Poly Medicure Ltd. provides information on the company's assets, liabilities, and equity. It is important to analyze the balance sheet to understand the financial position of the company. Our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, can help investors calculate the fair value of the company.

Poly Medicure Ltd. Annual Report

The annual report of Poly Medicure Ltd. provides a comprehensive overview of the company's performance over the year. It includes information on the company's financial statements, management discussion and analysis, and corporate governance. Investors can download the annual report from our website and analyze it to understand the company's performance.

Poly Medicure Ltd. Dividend

Poly Medicure Ltd. has a history of consistently paying dividends to its shareholders. Investors can analyze the company's dividend history to understand its dividend policy. It is important to analyze the dividend payout ratio to understand how much of the company's earnings are being distributed as dividends.

Poly Medicure Ltd. Quarterly Result

The quarterly results of Poly Medicure Ltd. provide information on the company's performance over the quarter. It includes information on the company's revenue, net profit, and earnings per share. Investors can download the quarterly results from our website and analyze them to understand the company's performance.

Poly Medicure Ltd. Stock Price

The stock price of Poly Medicure Ltd. is influenced by various factors such as market conditions, company performance, and news. Investors can analyze the stock price to understand the market's perception of the company's performance. Our pre-built screening tools can help investors analyze the stock price and its trend.

Poly Medicure Ltd. Price Chart

The price chart of Poly Medicure Ltd. provides a visual representation of the stock price trend over a period of time. Investors can analyze the price chart to understand the trend of the stock price. Our pre-built screening tools can help investors analyze the price chart and its trend.

Poly Medicure Ltd. News

News plays an important role in influencing the stock price of Poly Medicure Ltd. Investors can analyze the news related to the company to understand its impact on the stock price. Our pre-built screening tools can help investors analyze the news related to the company.

Poly Medicure Ltd. Concall Transcripts

The concall transcripts of Poly Medicure Ltd. provide information on the company's performance and management's outlook for the future. Investors can download the concall transcripts from our website and analyze them to understand the company's performance.

Poly Medicure Ltd. Investor Presentations

The investor presentations of Poly Medicure Ltd. provide information on the company's strategy, performance, and outlook for the future. Investors can download the investor presentations from our website and analyze them to understand the company's performance.

Poly Medicure Ltd. Promoters

The promoters of Poly Medicure Ltd. are the individuals or entities that hold a significant stake in the company. It is important to analyze the promoters to understand their track record and their influence on the company's performance.

Poly Medicure Ltd. Shareholders

The shareholders of Poly Medicure Ltd. are the individuals or entities that own a stake in the company. It is important to analyze the shareholders to understand their influence on the company's performance.

Poly Medicure Ltd. ROCE

Return on Capital Employed (ROCE) serves as a crucial metric for assessing Poly Medicure Ltd.'s profitability and capital utilization. Investors can find the ROCE data for Poly Medicure Ltd. in the financials table or ratio section above, enabling them to gauge how effectively the company is generating returns from capital investments and utilizing its resources to create value for shareholders.

Poly Medicure Ltd. EBITDA

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) acts as a key indicator of Poly Medicure Ltd.'s operational performance and cash flow generation. By eliminating interest, taxes, and non-cash expenses such as depreciation and amortization, EBITDA reveals Poly Medicure Ltd.'s core profitability. Investors can access the EBITDA data for Poly Medicure Ltd. in the financials table or ratio section above to gain insights into the company's financial health.

Poly Medicure Ltd. DPS

Dividends Per Share (DPS) serves as a significant metric for income-seeking investors, representing Poly Medicure Ltd.'s dividend distribution relative to its share count. By reviewing the DPS data available in the financials table or ratio section above, investors can evaluate the company's dividend payment history and its commitment to maximizing investor returns.

Poly Medicure Ltd. EPS

Earnings Per Share (EPS) provides valuable insights into Poly Medicure Ltd.'s profitability on a per-share basis. By dividing the net income by the number of outstanding shares, EPS helps investors assess the company's earning potential and growth prospects. Investors can find the EPS data for Poly Medicure Ltd. in the financials table or ratio section above and use it to evaluate the company's financial performance in terms of earnings generated for shareholders per share.  

Poly Medicure Balance Sheet Overview

Poly Medicure's Equity and Liabilities Growth

Poly Medicure has shown notable growth in its equity and liabilities over the recent years. From March 2020 to March 2024, the company's share capital slightly increased from Rs Cr. 44.12 to Rs Cr. 47.99. Total reserves saw a substantial rise from Rs Cr. 385.16 in March 2020 to Rs Cr. 1,410.26 by March 2024, indicating strong retention of earnings and possibly a robust reinvestment strategy.

Poly Medicure's Decreasing Debt

An impressive aspect of Poly Medicure's balance sheet is the significant reduction in borrowings, which plummeted from Rs Cr. 110.57 in March 2020 to a mere Rs Cr. 1.09 by March 2024. This suggests a strategic move towards minimizing debt and potentially signifies a stronger financial health and lower risk profile for the company.

Poly Medicure's Asset Expansion

The asset side of the balance sheet reflects healthy growth. The Net Block, representing tangible assets, grew from Rs Cr. 324.16 in March 2020 to Rs Cr. 830.82 by March 2024, underscoring considerable investments in the company's operational capabilities. Current assets also saw a rise from Rs Cr. 325.40 to Rs Cr. 864.59 in the same period, likely supporting the company's operational liquidity.

This data is an analysis for the Standalone Balance Sheet of the company.

Additionally, Poly Medicure's evolving balance sheet dynamics could be an interesting aspect for those involved in stock screening, offering insights into its financial health and operational efficiency in comparison to other players within the healthcare sector or listed on NSE/BSE indices.

Read More
X